Patients suffering from chronic pelvic pain syndromes, including irritable bowel syndrome (IBS), commonly report symptom onset or increased severity during periods of high stress ([@bib51], [@bib15]). Many IBS patients also have difficulty coping with stressful situations and suffer from depression, anxiety, and/or panic disorder ([@bib30]). Comorbidity between IBS and mood disorders has been associated with altered functioning of the hypothalamic-pituitary-adrenal (HPA) axis ([@bib17]), which regulates the response to stress and influences the perception of pain ([@bib73]). A history of adverse events early in life has been shown to permanently influence the functioning of the HPA axis and also increases the likelihood of developing IBS ([@bib11], [@bib20], [@bib85]).

Corticotropin-releasing factor (CRF) is the primary initiator of the HPA axis and acts both centrally and peripherally in response to an acute or chronic stressor ([@bib79], [@bib64]). Centrally, CRF is expressed in the paraventricular nucleus of the hypothalamus, and initiates a cascade through the HPA axis to induce a systemic release of glucocorticoids. Two CRF receptors, CRF receptor 1 (CRF~1~) and CRF receptor 2 (CRF~2~), largely work in opposition of one another to propagate and diminish HPA axis activation, respectively ([@bib67], [@bib5]). These two CRF receptors are also found peripherally, specifically within the mucosal layer of the colon, enteric nervous system, and innate inflammatory cells ([@bib58]). When released peripherally, CRF effects changes in neuroimmune function, partially through mast cell activation and degranulation ([@bib14]), resulting in increased cytokine and growth factor expression, sensitization of nerve endings, and endothelial leakage of associated vasculature ([@bib74], [@bib77], [@bib7], [@bib12]).

Neonatal maternal separation (NMS) is a well-established model of early life stress that has been shown to induce colorectal hypersensitivity ([@bib25], [@bib86], [@bib60], [@bib54]) and increase colonic permeability ([@bib82], [@bib32], [@bib84]), largely driven by dysregulation of the HPA axis ([@bib55], [@bib56]). Rodents exposed to NMS are more susceptible to experimental colitis ([@bib82]) and have demonstrated increased CRF receptor, growth factor, and cytokine mRNA expression in the adult distal colon and, in particular, IL-6 and CRF have been shown to interactively alter colonic secretory activity ([@bib9], [@bib61], [@bib57]). Introduction of an adult stressor, generally in the form of water avoidance stress (WAS), exacerbates the colorectal hypersensitivity of NMS rodents and can be attenuated by central or peripheral administration of CRF receptor antagonists ([@bib72], [@bib81]).

We have previously shown that NMS results in perigenital mechanical hypersensitivity in male mice ([@bib31]) and vaginal ([@bib66]) and bladder ([@bib65]) hypersensitivity in female mice, with varying adult stress-induced changes. Here we are testing the hypothesis that NMS in male mice will increase susceptibility to colorectal hypersensitivity following adult stress exposure or experimental colitis. We have measured the visceromotor response (VMR) during colorectal distension (CRD) at baseline and following exposure to increasing doses of Trinitrobenzene sulfonic acid (TNBS) or acute or chronic exposure to WAS. We also assayed the distal colon for Interleukin (IL)-6 and artemin mRNA levels and CRF receptor protein levels.

1. Experimental procedures {#sec1}
==========================

1.1. Animals {#sec1.1}
------------

Experiments were performed on male C57Bl/6 mice (Charles River, Wilmington, MA; ages listed in [Table 1](#tbl1){ref-type="table"}) born and housed in the Research Support Facility at the University of Kansas Medical Center. Mice were housed on a 12-h light cycle from 600 to 1800 h and received water and food (8604; Harlan Teklad, Madison WI) ad libitum. All research performed conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals in accordance with the guidelines specified by the University of Kansas Medical Center Animal Care and Use Protocols.Table 1Age of mice at experimental time points.Table 1BaselineInsultPost-insult measurements**Colorectal distension**No insult (n = 10)13Saline (n = 6)8910TNBS 2 mg (n = 6)101112TNBS 5 mg (n = 6)89101d WAS (n = 6)1010117d WAS (n = 6)1010--1112**Open Field**CRD (n = 8)61317**Hindpaw Sensitivity**CRD (n = 8)71319[^1]

1.2. Neonatal maternal separation {#sec1.2}
---------------------------------

Beginning on postnatal day 1 (P1, date of birth was considered P0), pups were removed daily from their home cages for 180 min (generally 1100--1400 h) and placed as a litter, with a small amount of home bedding material, into a clean glass beaker and held at 34 °C and 50% humidity as previously described ([@bib31]). NMS mice were weighed immediately prior to and after the NMS period from P1 through P14 or P21 and were weaned at P22. Naïve mice were born in-house and remained undisturbed in their home cages, with the exception of daily weighing and routine animal husbandry, until weaning at P22. Five separate cohorts of NMS mice were used in this study and each cohort was compared to a corresponding naïve group of mice that were born, housed, and weaned during the same time frame to avoid potential complications arising from variations in prenatal shipping conditions, housing environment, and investigator handling.

1.3. Trinitrobenzene sulfonic acid (TNBS) treatment {#sec1.3}
---------------------------------------------------

Naïve and NMS mice were anesthetized with inhaled isoflurane (4% induction, 2% maintenance) and secured on a platform that elevated the pelvic region approximately 5 cm above the working surface. A water-based lubricant (KY Jelly, Johnson & Johnson, New Brunswick, NJ) was liberally applied to the perianal region to avoid sensitization of surrounding somatic tissues. Mice received an intracolonic instillation of TNBS (0.1 ml of 50 mg ml^−1^ or 20 mg ml^−1^ in 50% EtOH) or saline (0.1 ml) using an oral feeding needle attached to a 50 μl Hamilton syringe. Mice remained in an elevated position for 5 min to prevent leakage. Mice were then allowed to recover from anesthesia and were returned to their home cages.

1.4. Water avoidance stress {#sec1.4}
---------------------------

Water avoidance stress (WAS) was performed for 1 h, within the first 6 h of the light cycle, for 1 day or 7 consecutive days. Mice were placed individually on a round platform (5 cm diameter) centrally affixed to the bottom of a container (36 cm length x 31 cm width x 27 cm height) filled with room temperature tap water up to 1 cm below the top of the platform.

1.5. Electromyographic electrode implantation and colorectal distension {#sec1.5}
-----------------------------------------------------------------------

The visceromotor response (VMR) to colorectal distension (CRD) was evaluated in naïve and NMS mice. Electrode implantation was performed as previously described ([@bib21]). Under inhaled isoflurane (4% induction, 2.5% maintenance) and aseptic conditions, the bare ends of two Teflon-coated stainless steel wires (3 mm; Grass Technologies, West Warwick, RI) were inserted into the right lateral abdominal musculature, secured via 5-0 prolene sutures, tunneled subcutaneously to a small incision made in the nape of the neck, and externalized for access during testing. Skin incisions were closed using 5-0 silk suture. Following recovery from anesthesia, mice were housed singly and allowed to recover for a minimum of 4 days before undergoing testing.

To facilitate balloon insertion and obtain proper restraint during CRD, mice were briefly sedated with inhaled isoflurane (4% induction, 2.5% maintenance) and a custom-made, catheterized polyethylene plastic balloon (1.5 cm length × 0.8 cm diameter) was inserted through the anus until the proximal end of the balloon was 0.5 cm from the anal verge (total balloon insertion, 2 cm) and secured to the base of the tail with tape. The mouse was then placed into a Broome-style rodent restraint (Kent Scientific, Torrington, CT), the free ends of the electrode wires were attached to a differential amplifier (Model 1700, A-M Systems, Sequim, WA), and the mice were allowed to recover from anesthesia for 30 min. The balloon was inflated with air from a compressed nitrogen tank equipped with a dual-stage low delivery pressure regulator (Matheson-Linweld, Kansas City, MO) and a separate pressure monitor (World Precision Instruments, Sarasota, FL) was used to manually regulate the pressure inside of the balloon. Each pressure (15, 30, 45, 60, and 75 mmHg) was applied three times for 20 s with a 4-min rest period in between. A custom-made distension control device (The University of Iowa Medical Instruments, Iowa City, IA) was used to control the gas flow through the system. Electromyographic (EMG) activity was amplified, filtered, and recorded on a personal computer with Spike 2 software (Cambridge Electronic Design, Cambridge, UK) for off-line analysis. The VMR was quantified by measuring the area under the curve for the entire distension period divided by the duration of the distension and expressed as a percent of baseline activity (10s prior to CRD).

1.6. Behavioral analysis {#sec1.6}
------------------------

All mice underwent a 30-min acclimatization period within the testing room for at least one day prior to each behavioral test. For both thermal and mechanical hindpaw sensitivity testing, the mice were allowed to acclimate to the apparatus for 30 min prior to testing and the experimenter was blinded to the group status of the mice.

### 1.6.1. Open field testing {#sec1.6.1}

Activity in naïve and NMS mice was measured using a Force Plate Actimeter (BASi, San Diego, CA), which consists of a rigid, low-mass horizontal plate (44 cm × 44 cm) coupled to high sensitivity force transducers on each corner. A Plexiglas enclosure rests a few millimeters above the plate to create a transparent enclosure, all of which rests within a light and sound-attenuated box. Animals were individually placed into the middle of the testing arena and allowed to move freely for 10 min. During this time, the software recorded the distance traveled and position of the mouse. The total distance traveled and percent of time spent in the perimeter (outermost 8.25 cm; increased time spent in the perimeter is indicative of anxiety ([@bib4])) was calculated and binned and the data from the second 5 min bin is reported here.

### 1.6.2. Thermal analgesiometer testing {#sec1.6.2}

Naïve and NMS mice were placed in individual clear plastic chambers (11 × 5 × 3.5 cm) on the 30 °C heated glass surface of a thermal analgesiometer (UARDG; Department of Anesthesiology, University of California San Diego, La Jolla, CA). A high intensity light (4.25 A) was directed at the plantar aspect of the hindpaw and the latency to withdrawal from the stimulus was automatically recorded within 0.01 s. Alternating hindpaws were tested for a total of three times per side with a minimum of 5 min between applications. The stimulus terminated automatically at 20 s to avoid tissue damage. Individual responses were averaged and group means were determined as previously described ([@bib22]).

### 1.6.3. Von Frey monofilament testing {#sec1.6.3}

Naïve and NMS mice were placed into individual clear plastic chambers (11 × 5 × 3.5 cm) on a wire mesh screen elevated 55 cm above a table. The up-down method was performed to test mechanical sensitivity using a standard set of von Frey monofilaments (1.65, 2.36, 2.83, 3.22, 3.61, 4.08, 4.31, 4.74 g; Stoelting, Wood Dale, IL)([@bib28]). Beginning with the 3.22 g monofilament, mice received a single application to the plantar surface of the right hindpaw. A negative response was followed by the next larger filament and a positive response (considered a brisk withdrawal of the paw) was followed by the next smaller filament. The experimenter continued to move up or down the series, depending on the previously elicited response, for an additional four applications after the first positive response was observed for a minimum of five or a maximum of nine total monofilament applications. The value in log units of the final von Frey monofilament applied in the trial series was used to calculate a 50% g threshold for each mouse and group means were determined as previously described ([@bib18]).

1.7. Myeloperoxidase assay {#sec1.7}
--------------------------

Mice were overdosed with inhaled isoflurane (\>5%) and the distal 1.5 cm of colon was dissected and the fecal matter, excess blood vessels, and mesentery were removed. The tissue was weighed, added to a beaker containing 1 ml 0.5% hexadecyltrumethylammonium bromide (HTAB; Sigma), and finely minced using spring scissors. The solution was transferred to a 15 ml centrifuge tube, along with another 2 ml HTAB, and sonicated for 10 s before being homogenized for 30 s. Another 2 ml HTAB was added and the tube was placed on dry ice until all samples were similarly processed. The samples underwent three freeze-thaw cycles, were centrifuged twice, and loaded in triplicate, along with MPO standards (Calbiochem, San Diego, CA), onto a 96-well plate. The standards and samples were reacted with O-dianisidine dihydrochloride (Sigma) and read on a plate reader at 460 nm every 20 s for 15 min. The slope for each standard reading was calculated and plotted and the slope of those values was used to calculate the units of MPO activity/tissue weight for each sample.

1.8. mRNA extraction and qRT-PCR {#sec1.8}
--------------------------------

Mice were overdosed with inhaled isoflurane (\>5%) and transcardially perfused with ice cold 0.9% saline. The 1.5 cm distal segment of the colon was removed, bisected longitudinally (to facilitate both mRNA and protein \[see below\] analysis), snap frozen in liquid nitrogen, and stored at −80 °C. Total RNA was isolated using Trizol reagent (Ambion, Austin, TX) and RNeasy Mini Kit (Qiagen, Valencia, CA). The concentration and purity were determined using a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA) and cDNA was synthesized from total RNA (0.63 μg) using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Quantitative RT-PCR was performed using SsoAdvanced SYBR Green Supermix (Bio-Rad) and a Bio-Rad iCycler IQ real time PCR system with indicated 20 μM primers (Integrated DNA Technologies, Coralville, IA) for interleukin-6 (IL-6; forward: CTGCCAGAGACTTCCATCCAGTT, reverse: GAAGTAGGGAAGGCCGTGG), artemin (forward: GGCCAACCCTAGCTGTTCT, reverse: TGGGTCCAGGGAAGCTT), with β-actin (forward: AGTGTGACGTTGACATCCGTA, reverse: GCCAGAGCAGTAATCTCCTTCT) used as a control. Samples were run in triplicate and negative control reactions were run with each amplification series. To reduce variability among efficiency due to fluctuations in baseline fluorescence, the raw (i.e. non-baseline corrected) PCR data was imported to the LinRegPCR software (version 2012.3) ([@bib68], [@bib71], [@bib78]) and PCR efficiency values were derived for each individual sample by fitting a regression line to a subset of data points within the sample\'s log-linear phase. Threshold cycle (Ct) values were subtracted from that of the selected housekeeping gene and the percentage of fold change over naïve controls was calculated using the Pfaffl method ([@bib63]).

1.9. Western blot {#sec1.9}
-----------------

Total protein was isolated from approximately 50 mg of snap-frozen colon using Cell Extraction Buffer (Invitrogen, Grand Island, NY) containing Halt protease and phosphatase inhibitors (ThermoFisher Scientific, Waltham, MA) and Na~3~VO~4~ (Sigma, St. Louis, MO). Protein concentrations were determined using a D~C~ protein assay (ThermoFisher). Samples were reduced by heating to 95 °C for 5 min in the presence of 2-mercaptoethanol, subjected to SDS-PAGE (Criterion 4%--12% Bis-Tris gels; Bio-Rad, Hercules, CA), and transferred to Nitrocellulose transfer membrane (Whatman GmbH, Dassel, Germany) by Criterion Blotter wet transfer (Bio-Rad). The membranes were blocked for 1 h at room temperature in 5% milk in Tris-buffered saline with Tween-20 (TBST) and incubated overnight at 4 °C with antisera to CRF~1~ (1:250; Millipore, Billerica, MA), CRF~2~ (1:1000; Millipore), and GAPDH (1:2000; Cell Signaling Technology, Danvers, MA) diluted in 5% milk in TBST. Membranes were then washed with TBST and incubated for 1 h with anti-rabbit secondary antibody (1:2000; Cell Signaling, Danvers, MA). Densitometry was performed using Quantity One 4.6.9 software (Bio-Rad).

1.10. Statistics {#sec1.10}
----------------

Calculations were made using Microsoft Excel and statistical analysis was performed using Student\'s t-test or 2-way (with or without repeated measures) analysis of variance (ANOVA) followed by Bonferroni\'s posttest (GraphPad Prism 6, GraphPad Software, La Jolla, CA), as denoted in the manuscript. All data are expressed as mean ± SEM. A *p* value of less than 0.05 was considered significant.

2. Results {#sec2}
==========

2.1. NMS increases hindpaw sensitivity, but not baseline colorectal sensitivity or anxiety measures {#sec2.1}
---------------------------------------------------------------------------------------------------

Male mice underwent NMS or remained unhandled (naïve) for the first 21 days of life and were assessed as adults for susceptibility to colorectal inflammation and acute or chronic exposure to WAS ([Table 1](#tbl1){ref-type="table"}). At baseline, naïve and NMS mice were not remarkably different in regards to colorectal sensitivity, measured as the VMR during CRD ([Fig. 1](#fig1){ref-type="fig"}A). Open field exploratory behavior and hindpaw mechanical and thermal sensitivity were also measured in naïve and NMS mice at baseline and following CRD. The percent of time spent in the perimeter of the open field was not significantly different between naïve and NMS mice at baseline; however, exposure to CRD significantly increased overall time spent in the perimeter, specifically in NMS mice ([Fig. 1](#fig1){ref-type="fig"}B). The withdrawal threshold to application of von Frey monofilaments to the plantar surface of the hindpaw was significantly reduced in NMS mice, particularly post-CRD ([Fig. 1](#fig1){ref-type="fig"}C). Thermal withdrawal latency to a radiant heat source on the plantar surface of the hindpaw was significantly shorter in NMS mice at baseline, but not following CRD ([Fig. 1](#fig1){ref-type="fig"}D).Fig. 1The visceromotor response (VMR) during colorectal distension (CRD) was measured, as well as open field activity and mechanical and thermal hindpaw sensitivity prior to and following CRD, in male mice that did and did not (naïve) undergo neonatal maternal separation (NMS). A) No difference in VMR, measured as the electromyographic (EMG) activity of the abdominal muscles during CRD, was observed between naïve and NMS mice. B) At baseline, naïve and NMS mice spent a similar percent of time in the perimeter of an open field; however, following exposure to CRD, there was an overall significant increase in the percent of time spent in the perimeter, specifically in NMS mice. C) Mechanical hindpaw withdrawal thresholds were significantly reduced in NMS mice across both measurements, particularly post-CRD. D) Thermal hindpaw withdrawal latencies were significantly shorter in NMS mice at baseline, compared to naïve, but not post-CRD. An overall effect of NMS and an NMS/CRD interaction was observed across both measurements. Brackets indicate a significant effect of NMS (\*, \*\**p* \< 0.05, 0.01), CRD (\#\#*p* \< 0.01), or an NMS/CRD interaction (+*p* \< 0.05) two-way RM ANOVA; \*, \*\**p* \< 0.05, 0.01 vs. naïve, \#*p* \< 0.05 vs. BL, Bonferroni posttest.Fig. 1

2.2. NMS increases susceptibility to TNBS {#sec2.2}
-----------------------------------------

To determine whether NMS increased susceptibility to experimental colitis, two different concentrations of TNBS were applied intracolonically. Application of 2mg/mouse TNBS did not significantly alter body weight, survival, or colorectal sensitivity of naïve or NMS mice, compared to saline-treated counterparts, over the 4 days immediately following treatment ([Fig. 2](#fig2){ref-type="fig"}). However, 5mg/mouse TNBS resulted in significant weight loss in NMS mice, compared to both 5 mg TNBS-treated naïve mice and saline-treated NMS mice ([Fig. 2](#fig2){ref-type="fig"}B) and also decreased survival rate in NMS mice, compared to 5 mg TNBS-treated naïve mice (16.7% ± 15.2 vs. 100%; *p* = 0.0006, Log-rank Mantel-Cox test). Neutrophil activation was measured by MPO activity and NMS mice that were separated for only the first 14 days of life and treated with 5 mg TNBS had significantly higher MPO at 4 d post-treatment compared to baseline NMS measurements ([Table 2](#tbl2){ref-type="table"}). NMS had a significant impact on colorectal sensitivity in both the saline-treated and 5 mg TNBS-treated groups; however, TNBS treatment showed no significant impact on colorectal sensitivity in either NMS or naïve mice ([Fig. 2](#fig2){ref-type="fig"}A).Fig. 2Mice that underwent neonatal maternal separation (NMS) were dose-dependently susceptible to intracolonic administration of trinitrobenzene sulfonic acid (TNBS). Mice were assessed for colorectal sensitivity and weighed to determine baseline (BL) measurements and then treated with saline, 2 mg TNBS, or 5 mg TNBS. Body weight was measured daily and colorectal distension (CRD) was performed on day 4 post-TNBS. A) The total electromyographic (EMG) activity is expressed as the area under the curve (AUC) for the entire CRD pressure series. No treatment effects were observed for saline, 2 mg TNBS, or 5 mg TNBS; however, NMS significantly impacted VMR in the saline-treated and 5 mg TNBS-treated groups. B) NMS mice given 5 mg TNBS lost significantly more body weight over three subsequent days than either naïve mice treated with 5 mg TNBS or saline-treated NMS mice. Brackets indicate a significant effect of NMS (\**p* \< 0.05), two-way RM ANOVA; \*, \*\**p* \< 0.05, 0.01 vs. naïve, \#, \#\#*p* \< 0.05, 0.01 vs. saline, Bonferroni posttest.Fig. 2Table 2Myeloperoxidase activity following Trinitrobenzene sulfonic acid treatment.Table 2NaïveNMS^‡^Baseline (n = 3)0.852 ± 0.200.606 ± 0.251d post (n = 4)6.43 ± 1.648.06 ± 0.774d post (n = 4)4.75 ± 1.8112.12 ± 3.81^\#\#^[^2]

2.3. NMS enhances acute WAS-induced colorectal hypersensitivity {#sec2.3}
---------------------------------------------------------------

Colorectal sensitivity was measured prior to and 1 d after either a single exposure to 1 h of WAS (1d WAS) or 7 consecutive daily exposures to 1 h of WAS (7d WAS) to determine susceptibility to acute or chronic stress, respectively. The VMR during the entire CRD series was significantly higher in NMS mice exposed to 1d WAS compared to their baseline measurements ([Fig. 3](#fig3){ref-type="fig"}A). In particular, the VMR at 60 and 75 mmHg was significantly higher in NMS mice after 1d WAS than both their baseline measurements and that of their naïve counterparts ([Fig. 3](#fig3){ref-type="fig"}A). Exposure to 1d WAS did not significantly impact the VMR of naïve mice ([Fig. 3](#fig3){ref-type="fig"}A). Exposure to 7d WAS did not significantly impact the VMR of either naïve or NMS mice ([Fig. 3](#fig3){ref-type="fig"}B).Fig. 3Acute, but not chronic, exposure to water avoidance stress (WAS) selectively increased colorectal sensitivity in NMS mice. A) The electromyographic (EMG) activity of the abdominal musculature was measured to determine the visceromotor response (VMR) to colorectal distension (CRD) both prior to (baseline) and 1 d after a single exposure to WAS (1d WAS) in naïve and NMS mice. Exposure to 1d WAS significantly increased VMR of NMS mice compared to their baseline measurements. This was particularly evident at the highest balloon pressures applied, 60 and 75 mmHg. B) Chronic daily exposure to WAS (7d WAS) had no impact on VMR during CRD in either naïve or NMS mice. Brackets indicate a significant effect of WAS (\#*p* \< 0.05), two-way RM ANOVA; \*\**p* \< 0.01 vs. naïve, \#, \#\#\#*p* \< 0.05, 0.001 vs. baseline, Bonferroni posttest.Fig. 3

2.4. NMS blunted TNBS and WAS-induced inflammatory gene expression and increased CRF receptor expression in the colon {#sec2.4}
---------------------------------------------------------------------------------------------------------------------

The impact of NMS, TNBS, and WAS on pro-inflammatory gene expression in the distal colon was evaluated by RT-PCR. Treatment with 5 mg TNBS induced a trend toward increased IL-6 and Artemin mRNA levels in the distal colon of naïve mice, which was not present in NMS mice ([Fig. 4](#fig4){ref-type="fig"}A). Indeed, artemin mRNA levels were significantly lower in NMS colon compared to naïve, particularly following TNBS treatment ([Fig. 4](#fig4){ref-type="fig"}A). Exposure to 1d WAS significantly increased IL-6 mRNA levels in naïve colon and the mRNA levels of IL-6 trended toward a significant increase in NMS mice, (*p* = 0.0525, two-way ANOVA; [Fig. 4](#fig4){ref-type="fig"}B). Exposure to 1d WAS had no impact on artemin mRNA levels in the colon of either naïve or NMS mice ([Fig. 4](#fig4){ref-type="fig"}B).Fig. 4Neonatal maternal separation (NMS) alters localized gene and protein expression changes in response to inflammation and acute stress. A) Real-time PCR was performed on mRNA from naïve and NMS distal colon following saline or 5 mg trinitrobenzene sulfonic acid (TNBS) treatment. A non-significant increase in interleukin (IL)-6 mRNA levels was observed in naïve colon following TNBS treatment, with a corresponding decrease in both IL-6 and artemin mRNA levels in NMS colon. B) Exposure to 1d WAS significantly increased IL-6 mRNA levels in naïve colon and NMS effected a trend toward increased IL-6 mRNA levels (*p* = 0.0525, two-way ANOVA). Artemin mRNA levels were unaffected by either NMS or WAS. C) Representative Western blots are shown for CRF~1~, CRF~2~, and corresponding GAPDH protein with bands at 55, 49, and 35kD, respectively. Exposure to 1d WAS had no effect on CRF~1~ protein levels in either naïve or NMS colon. At baseline, CRF~2~ protein levels were increased in NMS colon and exposure to 1d WAS significantly increased CRF~2~ protein levels, particularly in naïve colon. Brackets indicate a significant effect of NMS (\**p* \< 0.05) or WAS (\#*p* \< 0.05), two-way RM ANOVA; \**p* \< 0.05 vs. naïve, \#*p* \< 0.05 vs. baseline, Bonferroni posttest.Fig. 4

To determine the impact of 1d WAS on peripheral CRF receptor levels, Western blot was performed to measure CRF~1~ and CRF~2~ protein levels in the distal colon. Protein levels of CRF~1~ in the distal colon were not affected by NMS or 1d WAS ([Fig. 4](#fig4){ref-type="fig"}C). In contrast, 1d WAS exposure significantly increased CRF~2~ protein levels overall, specifically in naïve colon post-1d WAS compared to baseline levels ([Fig. 4](#fig4){ref-type="fig"}C). CRF~2~ protein levels were increased, though not significantly, in NMS colon both at baseline and post-1d WAS compared to baseline naïve levels ([Fig. 4](#fig4){ref-type="fig"}C).

3. Discussion {#sec3}
=============

Exposure to early life stress or trauma is a significant risk factor for developing several chronic pain syndromes, including IBS ([@bib11], [@bib20], [@bib85]). NMS has long been used in rodents to model both psychological disturbances and heightened colorectal sensitivity commonly experienced by IBS patients. Here, we performed a prolonged NMS paradigm in male mice and provided evidence of increased susceptibility of the distal colon to experimental colitis using TNBS and acute stress exposure, with accompanying alterations in pro-inflammatory gene/CRF receptor expression.

Rodent models of NMS ([@bib29], [@bib83], [@bib1], [@bib43]) and stress-sensitive strains of rodents ([@bib62]) have been shown to display behaviors indicative of increased anxiety and depression. We previously reported a significant decrease in baseline anxiety-like behavior and thermal and mechanical thresholds in the hindpaw of female NMS mice at baseline ([@bib66]). In the current study, male NMS mice displayed no significant change in anxiety-like behaviors, yet did have significantly shorter thermal withdrawal latencies at baseline. Further exposure to stress, in the form of CRD, significantly increased anxiety-like behaviors, similar to the increase observed in female NMS mice following vaginal balloon distension ([@bib66]). Interestingly, mechanical withdrawal thresholds were significantly lower in NMS than naïve mice, post-CRD; however, thermal withdrawal latencies were no longer significantly shorter in NMS mice. Exposure to VBD maintained decreased hindpaw thresholds in our previous study of female NMS mice ([@bib66]) and sex differences in behavioral outcomes following NMS have been previously reported ([@bib70], [@bib27]) and likely contribute to the more robust response in the female NMS mice, compared to the male.

Increased colorectal sensitivity is a commonly reported outcome of NMS and other manipulations of the stress-response system. High-anxiety strains of rats demonstrate significantly greater colorectal sensitivity than non-anxious strains ([@bib36], [@bib35], [@bib55], [@bib56])). Several studies of NMS in rats have reported increased colorectal sensitivity measured as either increased VMR ([@bib25], [@bib76], [@bib19]) or visualized abdominal withdrawal reflexes ([@bib70], [@bib23], [@bib69], [@bib33]) during CRD. In the current study, as well as in our previous study of female NMS mice ([@bib65]), we did not observe any evidence of colorectal sensitivity during CRD in NMS mice at baseline. This is in contrast to the significant perigenital mechanical sensitivity exhibited by male NMS mice ([@bib31]) and vaginal ([@bib66]) and bladder ([@bib65]) hypersensitivity exhibited by female NMS mice, suggesting that the NMS paradigm employed in our studies selectively sensitizes the urogenital system at baseline. To our knowledge, only one previous study has investigated colorectal sensitivity in NMS mice and reported a significant increase in VMR during CRD ([@bib54]). This study used BALB/c mice, which have been shown to be a higher anxiety strain than C57Bl/6 mice ([@bib13]), and incorporated NMS from P1-14 with concurrent maternal stress (forced swimming or restraint) during the separation period.

Evidence of increased susceptibility to experimental colitis was observed in NMS mice, despite the lack of increased colorectal sensitivity four days after treatment with either 2 or 5 mg TNBS. Previous studies of NMS in mice reported increased MPO and cytokine production, as well as elevated histological scores ([@bib82], [@bib32], [@bib84]). Here, we demonstrated a greater loss of body weight and decreased survival in NMS mice following 5 mg TNBS. Colonic MPO activity was continuing to increase at 4d post-TNBS in NMS mice, while MPO activity had decreased from its peak at 1d post-TNBS in naïve mice, as has been shown previously ([@bib49]), suggesting an exaggerated inflammatory response in NMS mice. Cytokine and growth factor production have also been shown to simultaneously increase in rodent models of colitis ([@bib6]) and ulcerative colitis patients have an increased production of pro-inflammatory cytokines ([@bib40]), as well as greater expression of neurotrophin receptors in peripheral nerve endings innervating the diseased colon ([@bib41]). Naïve mice treated with 5 mg TNBS showed a trend toward increased colonic IL-6 mRNA levels, which was not apparent in NMS colon. Two growth factors, nerve growth factor (NGF) and artemin, have been shown to dramatically increase following acute colitis in rodents ([@bib24], [@bib3], [@bib50]). Here we observed a slight, but not significant, increase in artemin mRNA levels in naïve mice following 5 mg TNBS and NMS colon actually showed a significant decrease in artemin mRNA levels compared to naïve colon. Colonic NGF mRNA was not significantly altered by 5 mg TNBS in either naïve or NMS mice (data not shown).

Symptom onset or exacerbation is often triggered by stress in patients suffering from IBS ([@bib30]). Clinically, peripheral administration of CRF has been shown to reduce the threshold to CRD and increase rectal compliance in human subjects ([@bib46]). Likewise, administration of CRF~1~ antagonist produced inhibitory effects within the emotional-arousal circuit of female IBS patients that were anticipating a painful stimulus ([@bib39]). A single exposure to WAS has previously been shown to increase VMR in NMS rats, but not in naïve rats ([@bib25], [@bib80], [@bib81]), whereas repeated exposure to WAS has been shown to significantly increase colorectal sensitivity in non-NMS rats ([@bib16], [@bib37]). In the current study, colorectal sensitivity in NMS mice was only increased by a single exposure to WAS and not following chronic exposure. The VMR of naïve mice was completely unaffected by either WAS treatment. Considering the paucity of studies investigating the impact of NMS or WAS on colorectal sensitivity in mice, it is possible that these stressors do not have the same impact across species. This theory is supported by our previous studies showing an impact of NMS on urogenital sensitivity in mice ([@bib66], [@bib65], [@bib31], [@bib65]), which has largely not been observed in rat models of NMS.

Rodents exposed to NMS demonstrate increased growth factor and cytokine expression, including NGF, IL-6, IL-1β, IL-2, IL-4, IL-10, and interferon (IFN)-γ ([@bib9], [@bib10], [@bib59], [@bib61]), as well as infiltration of mast cells ([@bib80], [@bib81], [@bib47]), in the distal colon, all of which can sensitize peripheral nociceptors and enhance visceral perception ([@bib9], [@bib10], [@bib26], [@bib59], [@bib61]). Mast cell infiltration and hypertrophy of sensory innervation has also been reported in biopsies from patients with IBS ([@bib7], [@bib8], [@bib2]). A single exposure to WAS elicited a significant increase in IL-6 mRNA levels in naïve colon, confirming that, despite the lack of physiological evidence, 1d WAS exposure did indeed significantly impact naïve colon. The mRNA levels of IL-6 in NMS mice trended toward a significant increase; however, the blunted effect of WAS on increasing IL-6 expression in NMS colon further suggests that neuroimmune responses to stress exposure are imbalanced following NMS exposure in mice.

A potential role for CRF in mediating comorbidity between psychological and chronic pain disorders has been investigated in both clinical and preclinical settings. Overactivity of central CRF~1~ signaling has been proposed to contribute towards comorbid anxiety/depression in female diarrhea-predominant IBS patients ([@bib75]). Associations between anxiety and voiding disorders have also been reported ([@bib44]) and interstitial cystitis (IC) patients with fibromyalgia, chronic fatigue syndrome, or rheumatoid arthritis had higher mean afternoon cortisol levels and increased pain during bladder filling than IC patients with no additional diagnoses ([@bib48]). In a study using repeated WAS exposure to induce colorectal sensitivity in non-NMS rats, treatment with a CRF~1~ antagonist treatment prior to, but not following, WAS prevented an increase in VMR ([@bib45]). However, treatment with astressin, a non-selective CRF~1~/CRF~2~ antagonist, only reduced the effect of WAS, suggesting that activation of CRF~2~ mediates colonic hypoalgesia. This observation is supported by studies showing that activation of CRF~2~ decreases CRF~1~-driven colorectal hypersensitivity ([@bib52], [@bib53]), cFos induction in the colonic myenteric ganglia, and increased colonic motility ([@bib34]). In the current study, protein levels of CRF~2~ were increased in NMS colon at baseline, similar to previous studies investigating mRNA levels in both male NMS rats ([@bib58]) and female NMS mice ([@bib66]). The protein levels of CRF~2~ were also increased in naïve colon following a single exposure to WAS. Urocortin signaling through CRF~2~ has been shown to increase IL-6 expression/release in cardiomyocytes and aortic smooth muscle cells ([@bib42], [@bib38]), and could be playing a similar mechanistic role here. The baseline increase in CRF~2~ protein in NMS colon may have primed the response to WAS, thereby increasing colorectal sensitivity, compared to naïve mice. Further investigation will be required to understand how the CRF receptors mediate colorectal sensitivity in mice and how stress at both early and late stages of life will impact their expression and activation patterns.

4. Conclusions {#sec4}
==============

We have tested the hypothesis that early life stress in male mice increases susceptibility to experimental colitis and adult stress exposure. Mice exposed to NMS show increased thermal hindpaw sensitivity at baseline with an increase in anxiety-like behaviors and mechanical hindpaw sensitivity following exposure to CRD. Intracolonic instillation of TNBS induces a dose-dependent loss in body weight and decreased survival rate in NMS mice. A single exposure to WAS, but not a 7 day repeated exposure, increased the VMR during CRD of NMS mice, and revealed evidence of improper neuroimmune response within the colon. Taken together, these results suggest that NMS in mice disrupts inflammatory- and stress-induced gene expression in the colon, potentially contributing towards an exaggerated response to specific stressors later in life.
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[^1]: Naïve and NMS mice underwent behavioral or physiological testing at the above noted ages (in weeks) prior to and/or following introduction of an insult, including colorectal distension (CRD), intracolonic trinitrobenzene sulfonic acid (TNBS), or acute (1d) or chronic (7d) exposure to water avoidance stress (WAS). Repeated tests were performed on the same mice for all CRD experiments involving post-insult measurements. Open field and hindpaw sensitivity tests were performed on separate groups of mice either at baseline or following CRD.

[^2]: Myeloperoxidase (MPO) activity (expressed as U mg^−1^ tissue weight) was measured in distal colon from naïve and NMS mice prior to (baseline) and following intracolonic instillation of 5 mg trinitrobenzene sulfonic acid (TNBS). Treatment with TNBS significantly increased MPO levels in both groups (*p* = 0.0071, two-way ANOVA). Naïve MPO levels peaked at 1d post-TNBS, while NMS MPO levels continued to increase at 4d post-TNBS. \#\#*p* \< 0.01 vs. baseline, Bonferroni posttest. ‡ denotes NMS (neonatal maternal separation) mice that were separated from postnatal day 1--14.
